Mylocar 60mg Injection contains carfilzomib, a proteasome inhibitor medicine used to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer affecting plasma cells in the bone marrow. It works by blocking the activity of proteasomes, which are cellular structures responsible for breaking down unneeded proteins in cancer cells. When proteasome function is stopped, harmful proteins build up inside the cancer cells, leading to cancer cell death and helping to control disease progression. Your doctor will decide if this treatment is suitable for your condition.

Mylocar 60mg Injection is administered intravenously (infusion into a vein) by a qualified healthcare professional in a hospital or clinic setting. Do not self‑administer. The exact dose, schedule, and duration depend on your medical condition, treatment plan, and response to therapy as determined by your doctor.

Common side effects may include fatigue, anemia (low red blood cell counts), nausea, low blood platelets, fever, and shortness of breath. This medicine may also reduce white blood cell counts, increasing the risk of infections. Serious side effects can occur, including severe reactions, heart or lung problems, or infusion reactions. Contact your doctor immediately if you experience severe or persistent symptoms.

You can obtain Mylocar 60mg Injection from licensed pharmacies or specialty cancer medicine suppliers with a valid prescription. Contact Macarius Health to check availability and pricing.

Store Mylocar 60mg Injection as advised by your healthcare provider or pharmacist. Typically, it should be refrigerated at 2°C to 8°C and protected from light. Keep it in its original packaging and out of reach of children and pets.

Inform your doctor about all medicines, supplements, or herbal products you are taking. Some medicines may interact with carfilzomib or increase the risk of side effects. Your doctor may adjust your treatment or monitoring if required.

Mylocar 60mg Injection is not recommended during pregnancy or while breastfeeding unless clearly advised by your doctor, as it may cause fetal harm and it is not known whether it passes into breast milk. Effective contraception should be used during treatment and for a period after stopping therapy. Discuss risks, benefits, and contraception requirements with your healthcare provider before starting treatment.

Delivery time depends on stock availability and location. Macarius Health arranges prompt delivery within Delhi NCR. For other cities across India, delivery typically follows standard courier timelines.